MSI

7 registered clinical trials studyying MSI — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer NCT06449989	Blokhin's Russian Cancer Research Center	—
Withdrawn	Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer NCT06152523	Assistance Publique - Hôpitaux de Paris	Phase 2
Completed	Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis NCT05604378	Saint Vincent's Hospital, Korea	—
Recruiting	Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorecta NCT05495776	State Scientific Centre of Coloproctology, Russian Federation	—
Completed	A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies NCT03652077	Incyte Corporation	Phase 1
Completed	Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer NCT03186326	Federation Francophone de Cancerologie Digestive	Phase 2
Terminated	Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer NCT02982694	Vall d'Hebron Institute of Oncology	Phase 2